Tania Tillett
Royal United Hospital Bath NHS Trust(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, Cancer Diagnosis and Treatment, COVID-19 Clinical Research Studies, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer(2021)183 cited
- → International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative(2023)119 cited
- → Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.(2019)60 cited
- → Management of uncommon chemotherapy-induced emergencies(2011)48 cited
- → Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer(2022)29 cited
- → A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)(2023)20 cited
- → Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative(2024)10 cited
- → Thromboembolic events with cisplatin-based neoadjuvant chemotherapy for transitional cell carcinoma of urinary bladder.(2013)3 cited
- → OPTIMIZING CHEMOTHERAPY FOR FRAIL AND/OR ELDERLY PATIENTS WITH ADVANCED GASTROESOPHAGEAL CANCER (AGOAC): THE GO2 PHASE III TRIAL(2019)3 cited
- → CUPCOMP: A multi-site UK trial in carcinoma of unknown primary: A comparison across tissue and liquid biomarkers.(2024)2 cited